Protokinetix Inc
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). Its AFGPs are used in various commercial applications comprising targeted health care solutions, as well as AAGPs are used for applications in ophthalmology, dermatology, transplants, and biomanufa… Read more
Protokinetix Inc (PKTX) - Total Assets
Latest total assets as of September 2025: $477.62K USD
Based on the latest financial reports, Protokinetix Inc (PKTX) holds total assets worth $477.62K USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Protokinetix Inc - Total Assets Trend (2000–2024)
This chart illustrates how Protokinetix Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Protokinetix Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Protokinetix Inc's total assets of $477.62K consist of -0.8% current assets and 100.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | -1.0% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $469.78K | 100.8% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2000–2024)
This chart illustrates how Protokinetix Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Protokinetix Inc's current assets represent -0.8% of total assets in 2024, a decrease from 100.0% in 2000.
- Cash Position: Cash and equivalents constituted -1.0% of total assets in 2024, down from 100.0% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 100.0% of total assets, an increase from 0.0% in 2000.
- Asset Diversification: The largest asset category is intangible assets at 100.8% of total assets.
Protokinetix Inc Competitors by Total Assets
Key competitors of Protokinetix Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Protokinetix Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Protokinetix Inc generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Protokinetix Inc is currently not profitable relative to its asset base.
Protokinetix Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.01 | 0.08 | 4.33 |
| Quick Ratio | 0.01 | 0.08 | 4.33 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-225.54K | $ -81.01K | $ 149.54K |
Protokinetix Inc - Advanced Valuation Insights
This section examines the relationship between Protokinetix Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 12.82 |
| Latest Market Cap to Assets Ratio | 4.37 |
| Asset Growth Rate (YoY) | -3.0% |
| Total Assets | $466.14K |
| Market Capitalization | $2.04 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Protokinetix Inc's assets at a significant premium ( 4.37x), suggesting investors see substantial growth potential or unique competitive advantages.
Slight Asset Contraction: Protokinetix Inc's assets decreased by 3.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Protokinetix Inc (2000–2024)
The table below shows the annual total assets of Protokinetix Inc from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $466.14K | -3.00% |
| 2023-12-31 | $480.56K | +3.82% |
| 2022-12-31 | $462.87K | +3.73% |
| 2021-12-31 | $446.23K | -4.89% |
| 2020-12-31 | $469.18K | -19.92% |
| 2019-12-31 | $585.91K | +80.36% |
| 2018-12-31 | $324.85K | -37.30% |
| 2017-12-31 | $518.10K | -4.43% |
| 2016-12-31 | $542.09K | +20.53% |
| 2015-12-31 | $449.75K | +7635.67% |
| 2014-12-31 | $5.81K | -76.41% |
| 2013-12-31 | $24.64K | -17.22% |
| 2011-12-31 | $29.77K | -56.96% |
| 2010-12-31 | $69.17K | -73.74% |
| 2009-12-31 | $263.41K | +2.41% |
| 2008-12-31 | $257.22K | +74.06% |
| 2007-12-31 | $147.78K | -75.93% |
| 2006-12-31 | $613.95K | -80.94% |
| 2005-12-31 | $3.22 Million | -12.09% |
| 2004-12-31 | $3.66 Million | +52.69% |
| 2003-12-31 | $2.40 Million | +414425.73% |
| 2002-12-31 | $579.00 | -88.79% |
| 2000-12-31 | $5.17K | -- |